| CALL
for VOLUNTEERS
Diabetes
The Department of Medicine at UMDNJ-Robert Wood Johnson
Medical School in New Brunswick is looking for volunteers between the
ages of 65 and 90 to participate in a 14-week diabetes study of an FDA-approved
diabetes medication. To be eligible, volunteers must not now be taking
medication to control their blood sugar. Participants will receive a physical
exam, study tablets and relevant laboratory tests at no cost.
The principal investigator for the study is Avedis K. Khachadurian,
MD. For more information call Shelley Greenhaus, RN, at 732-235-7751.
Diabetes Mellitus
An investigational drug study for diabetic neuropathy is
being conducted at UMDNJ-Robert Wood Johnson Medical School in New Brunswick.
Individuals with diabetes mellitus experiencing numbness or pain in their
hands or feet may be eligible to participate. Participants will receive
at no cost a physical exam, study tablets, relevant laboratory tests and
a nerve biopsy, which is required. Monetary compensation of $1,250 will
be provided upon completion of the study.
A second investigational drug study is being conducted at
the school to test a new diabetes pill for the treatment of Type II diabetes
mellitus. Volunteers with diabetes between the ages of 21 and 79 are needed
to participate. Monetary compensation is provided to those who qualify
and there is no charge for a physical exam, study medications and relevant
laboratory tests.
Stephen H. Schneider, MD, Division of Endocrinology, Metabolism
and Nutrition, is the principal investigator for both studies. For more
information on both studies, call Shelley Greenhaus, RN, at 732-235-7751.
Type II Diabetes
The Division of Endocrinology, Metabolism and Nutrition
at UMDNJ-Robert Wood Johnson Medical School in New Brunswick is conducting
an investigational drug study for individuals with Type II diabetes, between
the ages of 30 and 79, who are currently taking one or more oral medications
for diabetes. The drugs used in the study are FDA approved. Those considered
will receive free study medications, glucose monitoring supplies, relevant
laboratory tests and a physical exam. The study will provide a reasonable
reimbursement for time and travel up to a fixed amount.
Stephen H. Schneider, MD, is the principal investigator.
For more information call Shelley Greenhaus, RN, at 732-235-7751.
Women Needed to Participate in an Alzheimer’s Disease
Study
Women are being sought to participate in a three-year research
study to determine whether estrogen replacement therapy reduces the risk
of developing memory loss and maintains memory in older women who are
not currently experiencing memory problems. Participants must be age 65
and older and have had a parent or sibling diagnosed with Alzheimer’s
disease. Related medical care, including study medications,will be prescribed
at no cost while patients are enrolled in the study. Other screening and
eligibility requirements must also be met.
The study is being conducted at UMDNJ-Robert Wood Johnson
Medical School in Piscataway and is funded by the National Institutes
of Health. Peter Aupperle, MD, University Behavioral HealthCare, is the
principal investigator. For more information call Julie Coleman, RN, BSN,
at 732-235-4907.
Down Syndrome
UMDNJ-Robert Wood Johnson Medical School in Piscataway is
conducting a 12-week study on Down syndrome. The goal of the study is
to determine if a drug which is FDA approved for the treatment of mild
to moderate dementia of Alzheimer’s type will improve attention,
language and memory in patients who have Down syndrome but no memory problems.
To qualify, volunteers must be between the ages of 18 and 35 and have
Down syndrome.
Participants and their caregiver or a family member are
required to attend a total of four sessions during the study period. Patients
will receive daily oral medication or inactive placebo. At the end of
the study, all participants will have the option of receiving active medication
for an additional 12 weeks.
The study is under the direction of the principal investigator
Peter Aupperle, MD, University Behavioral HealthCare. For additional information
call Julie Coleman, RN, BSN, at 732-235-4907.
Memory Loss
A research study is being conducted at UMDNJ-Robert Wood
Johnson Medical School in Piscataway. The goal of the 12-week study (includes
a total of five visits) is to evaluate the safety and effectiveness of
a drug that assists patients who have memory loss who are also experiencing
agitation, restlessness or anxiety. To be eligible, volunteers must be
age 60 and older and in good health with a diagnosis of memory loss due
to some type of dementia. Related medical care, including study medications,
will be prescribed at no cost while patients are enrolled. Other screening
and eligibility requirements must also be met.
William Reichman, MD, University Behavioral HealthCare,
is the principal investigator for the study. For more details call Julie
Coleman, RN, BSN, at 732-235-4907.
Environmental Health Research Study
Women are needed to participate in a study at UMDNJ-Robert
Wood Johnson Medical School in Piscataway to evaluate the health effects
of indoor air quality and stress. To be eligible, volunteers must be healthy
non-smokers between the ages of 20 and 45, and be available for a five
hour morning session (once a week) for four consecutive weeks. During
these sessions, responses to indoor air (typical of office environments)
will be measured. Participants will also fill out questionnaires, be given
tests of attention and concentration, and be asked to provide nasal and
saliva samples. A medical exam will be provided at no cost, and upon completion
of the study, participants will receive monetary compensation.
Nancy Fiedler, PhD, Environmental & Occupational Health
Sciences Institute, is the principal investigator for the study. For more
information call 732-445-0123, ext. 625.
Uterine Lining Study
The National Institutes of Health, in conjunction with the
Department of Obstetrics, Gynecology and Women’s Health, is conducting
a study to test the uterine lining in both fertile and infertile women.
To qualify, participants must be between the ages of 25 and 39, have regular
menstrual cycles and have had a child in the last 23 months. Participants
will be compensated for time and travel.
Peter McGovern, MD, is the principal investigator for the
study.For more information call the study coordinator Amy Solnica, RN,
at 201-393-7430 or 888-777-8922, ext. 7430.
Oral and Vaginal Hormone Treatment
Menopausal women experiencing vaginal dryness and painful
intercourse are being sought to participate in a seven-month oral and
vaginal hormone treatment study at UMDNJ-Robert Wood Johnson Medical School
in New Brunswick. Participants will receive a physical examination, mammogram,
laboratory test and Pap smear at no cost, and will be paid $175 upon completion
of the study. Monetary compensation will be prorated if the volunteer
does not complete the study.
Gloria Bachmann, MD, Women’s Health Institute, is the
principal investigator for the study. For more information call 732-235-7353
or 732-235-7799, Monday thru Friday from 8 AM to 4 PM.
Treatment for Osteoporosis in Postmenopausal Women
Postmenopausal women are needed to participate in a one
year medical research study for the treatment of osteoporosis at UMDNJ-Robert
Wood Johnson Medical School in New Brunswick. The study will collect information
on two approved, marketed medications for this condition.
Volunteers must be age 40 and older to be considered. Participants
will receive study medication, study related physician visits, laboratory
tests and bone density (osteoporosis) testing. In addition, they will
receive $150 upon the completion of the study.
Gloria Bachmann, MD, Women’s Health Institute, is the
principal investigator for the study. For more information call 732-235-7292
or 732-235-7799.
Psoriasis
The Clinical Research Center at UMDNJ-Robert Wood Johnson
Medical School in New Brunswick is seeking volunteers with psoriasis to
participate in research studies being conducted at the school. Eligible
participants will receive physical examinations by board-certified dermatologists,
laboratory tests and medication at no cost. Some programs have monetary
compensation.
This study is under the direction of Alice B. Gottlieb,
MD, PhD. For further details and to find out if you qualify, call Nancy
Olesinski at 732-418-8484.
Parkinson’s Disease
A group of neurologists from throughout the U.S. and Canada,
known as the Parkinson’s Study Group (PSG), have formed a collaborative
effort with Indiana University School of Medicine, University of Rochester,
The Ohio State University, Children’s Hospital Medical Center at
the University of Cincinnati and Emory University to study genetic and
other risk factors which may be important in the development of Parkinson’s
disease. This study, PROGENI (Parkinson’s Research: The Organized
Genetics Initiative), is being sponsored by the National Institutes of
Health and will involve 400-600 pairs of brothers and sisters throughout
North America who are affected, or possibly affected, with Parkinson’s
disease (PD).
Participation in this project is voluntary and will be limited
to those individuals with living siblings affected or possibly affected
with PD who are also willing to participate. To enroll in this project
or to request additional information, contact Lisa Giffin, LPN, CCRC,
Center for Aging in Stratford, at 856-566-6356. Those residing outside
the United States should call 1-317-274-5734. Information about the study
can also be obtained through a Web site (http://www.medgen.iupui.edu/research/parkinson).
Asthma
Non-smokers between the ages of 15 and 65 with a history
of asthma are needed to participate in a study to test a medication to
treat asthma. Participants will receive free testing, examinations and
generous compensation for time and travel.
The study is being conducted at Cooper Hospital/University
Medical Center’s Department of Medicine in Camden. The principal
investigator is Robin Gross, MD. For further information call Robin Gross,
MD, at 856-342-2407 or Patricia Niblack, MLT, at 856-968-7269.
Autism
At UMDNJ-New Jersey Medical School, a study is being conducted
to investigate how the brain analyzes facial expressions in people with
autism as compared with healthy individuals. It involves looking at photographs
of faces while a magnetic resonance imaging (MRI) scan is being performed.
Participants must be right-handed males between the ages of 18 and 30,
in good physical health and with no history of mental illness. They will
be required to make two visits to Newark over a period of a month and
will receive financial compensation for their time and travel.
Charles Cartwright, MD, Department of Psychiatry,
is the principal investigator. For more information call the Autism Program
at 973-972-1611.
top
|
